Author:
Teplyakov A T,Berezikova E N,Shilov S N,Grakova E V,Torim Yu Yu,Efremov A V,Popova A A,Pustovetova M G,Sabirova A Yu,Kopyeva K V
Abstract
Aim. To reveal the specific features of Fas ligand-mediated ischemic myocardial remodeling and those of chronic heart failure (CHF) development during a 12-month prospective follow-up. Subjects and methods. A total of 94 patients with ischemic CHF were examined and divided into 3 groups according to NYHA Functional Class (FC): 1) FC II CHF in 35 patients; 2) FC III CHF in 31; 3) FC IV CHF in 28. According to the results of the 12-month follow-up, the patients were randomized into 2 groups: A) 49 patients with a favorable course of cardiovascular disease and B) 45 patients with its poor course. Serum soluble Fas ligand (sFas-L) levels were measured by enzyme immunoassay. Results. In the patients with CHF, the baseline sFas-L levels substantially exceeded that in the control group by 3—6 times (p
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference23 articles.
1. Бузиашвили Ю.И., Ключников И.В., Мелконян А.М., Иноземцева Е.В., Коваленко О.А., Мамаев Х.К. Ишемическое ремоделирование левого желудочка (определение, патогенез, диагностика, медикаментозная и хирургическая коррекция). Кардиология. 2002;10:88-95.
2. Molecular and cellular mechanisms of myocardial remodeling
3. Cardiomyocyte apoptosis in the failing heart — A critical review from definition and classification of cell death
4. Ярилин А.А. Апоптоз. Природа феномена. Его роль в целостном организме. Патологическая физиология и экспериментальная терапия. 1998;2:43-48.
5. Striking a Balance: Autophagy, Apoptosis, and Necrosis in a Normal and Failing Heart
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献